Saturday 17 October 2026
Export RDGT’s income statement to Excel — free account
Ridgetech Inc.
RDGT Healthcare Pharmaceutical Retailers
Ridgetech Inc.’s revenue for fiscal 2026 (year ended March 2026) was $132.2 million, up 10.2% from fiscal 2025. Insiders bought in the last twelve months.
0.84
0.01
+1.20%
Follow RDGT
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 6 | 4 | 3 | 4 | 4 | 1 | 4 | 4 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 0.33 | 0.50 | 0.76 | 0.34 | 0.48 |
Altman Z-Score |
1.16 | 1.01 | 0.22 | 1,105.64 | 24.72 | 0.80 | 0.93 | 1.68 | 0.50 | 1.62 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 33.86 |
Altman Z″-Score (non-manufacturers) |
1.77 | 0.16 | (2.62) | (5.47) | (1.43) | (1.16) | (1.14) | (1.04) | (1.78) | 1.24 |
Beneish M-Score |
(2.32) | 0.88 | 0.60 | (3.80) | (2.15) | (2.72) | (1.53) | (1.99) | (3.53) | (3.00) |
P/Operating CF |
0.00 | 0.01 | 0.04 | 1.19 | 1.02 | 3.58 | 13.43 | 17.33 | 4.27 | 11.62 |
P/B ratio |
0.00 | 0.01 | 0.03 | 0.82 | 0.53 | 1.82 | 3.12 | 4.82 | 1.75 | 1.46 |
Price to Tangible BV |
0.00 | 0.01 | 0.04 | 1.00 | 0.62 | 2.12 | 3.81 | 6.12 | 2.23 | 1.62 |
EV/Sales |
(0.04) | (0.09) | (0.08) | (0.04) | (0.08) | 0.11 | 0.29 | 0.53 | 0.02 | 0.14 |
EV/EBITDA |
0.63 | 1.25 | 1.24 | 0.57 | 2.45 | 0.00 | 0.00 | 71.33 | 0.00 | 0.00 |
EV/Operating CF |
(1.26) | 3.11 | 3.07 | 1.42 | 3.59 | (225.33) | (4.91) | (10.19) | (0.77) | 7.19 |
EV/FCF |
(1.33) | 2.93 | 2.89 | 1.34 | 3.25 | (21.06) | (3.69) | (4.00) | (0.23) | 9.76 |
Quick Ratio |
2.00 | 1.42 | 0.14 | 0.73 | 0.78 | 0.82 | 0.80 | 0.69 | 0.79 | 0.97 |
Current Ratio |
2.31 | 1.74 | 0.94 | 0.97 | 1.01 | 1.11 | 1.06 | 1.02 | 1.14 | 1.40 |
Net Debt/EBITDA |
11.92 | (3.72) | (0.72) | 1.56 | 27.50 | 4.42 | 5.76 | 1.28 | 0.83 | 5.70 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.19% | 6.43% | 35.68% | 25.98% | 18.89% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 | 0.34 | 1.53 | 1.02 | 0.48 |
Asset Turnover |
1.98 | 1.50 | 1.33 | 1.51 | 1.55 | 1.29 | 1.36 | 1.47 | 1.36 | 1.26 |
Operating CF/Net income |
1.11 | 0.12 | 0.75 | 0.16 | 1.69 | 0.01 | 1.19 | 6.05 | 0.12 | (0.28) |
Capex/Depreciation |
0.00 | (0.10) | (0.17) | 0.00 | 0.00 | (0.35) | (1.10) | (4.36) | (2.10) | (0.31) |
Interest Coverage |
(27.81) | — | — | (47.35) | (12.67) | (18.91) | (9.13) | (7.76) | (34.32) | (3,062.38) |
| (3.55%) | 46.41% | (26.21%) | (100.42%) | (13.17%) | (37.61%) | (32.52%) | (5.17%) | (74.94%) | (24.55%) | |
| (1.87%) | 12.78% | (4.55%) | (21.42%) | (3.00%) | (7.89%) | (6.75%) | (1.26%) | (24.20%) | (8.73%) | |
ROIC |
(5.10%) | (5.83%) | 3.72% | 0.00% | 0.00% | 0.00% | 0.00% | (3.04%) | (160.14%) | (21.69%) |
Return on Tangible Assets |
(3.41%) | 40.20% | 90.68% | (119.84%) | (14.93%) | (58.48%) | (51.98%) | (9.53%) | (164.79%) | (27.93%) |
Average Days of Receivables |
104.92 | 91.98 | 18.41 | 41.32 | 49.96 | 50.65 | 46.17 | 44.56 | 43.37 | 48.51 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
5.01% | 4.06% | 3.45% | 37.10% | 23.76% | 28.43% | 27.19% | 24.16% | 38.04% | 25.29% |
Intangible Assets out of Total Assets |
0.06 | 0.07 | 0.01 | 0.04 | 0.03 | 0.03 | 0.03 | 0.05 | 0.06 | 0.04 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.96% | 0.03% | 0.18% | 7.31% | 2.76% |
Graham Net Nets |
5,077.13 | (56.69) | (18.37) | (0.66) | (0.65) | (0.22) | (0.34) | 0.01 | 0.22 | 0.40 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(272.22%) | (7.78%) | (2.52%) | (0.09%) | (46.75%) | (17.78%) | (9.90%) | (0.70%) | (52.43%) | (15.36%) |
Free Cash Flow Yield |
206,769.70% | (5,308.63%) | (1,720.39%) | (62.21%) | (44.41%) | (1.50%) | (15.67%) | (17.45%) | (20.77%) | 2.95% |
Revenue per Share |
1,817.93 | 3,242.48 | 12,782.90 | 14.59 | 567.07 | 121,031.45 | 130,364.11 | 134,438.75 | 137,303.86 | 135,831.83 |
Operating CF per Share |
(19.17) | 33.72 | (325.30) | (0.32) | (18.58) | (56.64) | (7,675.44) | (7,004.00) | (2,957.29) | 2,599.17 |
Capex per Share |
(0.01) | (16.63) | (95.23) | 0.00 | 0.00 | (549.27) | (2,537.56) | (9,136.37) | (4,145.71) | (685.33) |
Free Cash Flow per Share |
(19.18) | 17.09 | (420.53) | (0.32) | (18.58) | (605.91) | (10,213.00) | (16,140.37) | (7,103.00) | 1,913.83 |
Cash per Share |
246.41 | 501.11 | 441.86 | 3.10 | 122.23 | 31,603.73 | 34,599.78 | 31,157.63 | 45,181.86 | 46,471.50 |
Shareholders Equity per Share |
560.89 | 800.98 | 1,473.52 | 1.77 | 83.08 | 22,184.00 | 20,864.56 | 21,214.00 | 26,946.29 | 44,440.67 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 | 0.02 |
Book value per Share |
560.89 | 800.98 | 1,473.52 | 1.77 | 83.08 | 22,184.00 | 20,864.56 | 21,214.00 | 26,946.29 | 44,440.67 |
Free Cash Flow |
(1.39) | 0.63 | (4.08) | (3.28) | (5.39) | (0.67) | (9.19) | (12.91) | (4.97) | 1.15 |
Working Capital |
36.66 | 25.35 | (4.68) | (2.05) | 1.00 | 7.34 | 3.55 | 0.99 | 7.51 | 15.95 |
Capital Expenditures |
0.00 | (0.62) | (0.92) | (0.31) | (0.31) | (0.60) | (2.28) | (7.31) | (2.90) | (0.41) |
Net Current Asset Value |
36.31 | 24.86 | (11.08) | (9.82) | (8.19) | (9.67) | (19.75) | 0.44 | 7.37 | 15.45 |
EV/EBIT |
1.58 | 3.13 | 3.09 | 1.43 | 2.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 | 0.03 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
63.81 | 675.99 | 641.02 | 0.04 | 0.06 | 0.27 | 0.27 | 0.19 | 0.49 | 0.31 |
Cash ROIC |
(2.38%) | 1.31% | (21.96%) | (6.62%) | (9.05%) | (1.05%) | (16.32%) | (19.03%) | (7.14%) | 1.71% |
Accounts Receivable Turnover |
3.87 | 6.58 | 10.74 | 7.56 | 8.02 | 7.99 | 8.39 | 8.76 | 8.64 | 8.04 |
Accounts Payable Turnover |
6.01 | 4.62 | 4.14 | 4.22 | 4.47 | 4.04 | 4.11 | 3.41 | 3.40 | 3.59 |
Inventory Turnover |
14.14 | 12.33 | 9.71 | 7.15 | 7.62 | 7.11 | 7.01 | 6.02 | 6.51 | 6.26 |
Average Days of Payables |
65.20 | 61.81 | 93.70 | 86.02 | 78.01 | 105.03 | 85.72 | 102.30 | 121.33 | 109.39 |
Days of Inventory on Hand |
23.66 | 30.67 | 27.81 | 49.24 | 47.36 | 59.63 | 48.69 | 61.78 | 64.51 | 55.83 |
Average Receivables |
34.11 | 18.24 | 11.55 | 19.67 | 20.49 | 16.66 | 13.99 | 12.28 | 11.13 | 10.13 |
Average Payables |
21.21 | 25.12 | 28.78 | 27.16 | 28.61 | 25.73 | 22.33 | 24.18 | 22.35 | 18.05 |
Average Inventory |
9.01 | 9.42 | 12.26 | 16.02 | 16.78 | 14.61 | 13.10 | 13.69 | 11.68 | 10.36 |
Average Assets |
66.76 | 79.77 | 93.01 | 98.68 | 106.35 | 102.91 | 86.12 | 73.27 | 70.49 | 64.62 |
Average Common Equity |
35.21 | 21.96 | 16.15 | 21.05 | 24.24 | 21.59 | 17.87 | 17.92 | 22.76 | 22.99 |
Columns are period end dates